Paper715674
The necessity of increased doses of amikacin in burn patients.
Zaske DE and 2 others. Surgery, 1978. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. The necessity of increased doses of amikacin in burn patients. Papers, record 715674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/715674
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amikacin | Major topic |
| Bacterial Infections | Major topic |
| Burns | Major topic |
| Kanamycin | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Creatinine | |
| Half-Life | |
| Humans | |
| Infant | |
| Middle Aged |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32055559 | Augmented renal clearance. | Transl Clin Pharmacol | 2018 | https://conductscience.org/library/papers/32055559 | PubMed |
| 21825289 | Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21825289 | PubMed |
| 18783295 | Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. | Clin Pharmacokinet | 2008 | https://conductscience.org/library/papers/18783295 | PubMed |
| 16723549 | Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16723549 | PubMed |
| 16176116 | Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/16176116 | PubMed |
| 14503658 | Relative pharmacokinetics of three amikacin brands in onco-hemotologic pediatric patients experiencing febrile neutropeina. | Eur J Drug Metab Pharmacokinet | 2003 | https://conductscience.org/library/papers/14503658 | PubMed |
| 10582870 | Pharmacokinetics of cefepime in patients with thermal burn injury. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10582870 | PubMed |
| 9559811 | Fluconazole pharmacokinetics in burn patients. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9559811 | PubMed |
| 8787895 | Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8787895 | PubMed |
| 7586895 | Clinical pharmacokinetics in patients with burns. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7586895 | PubMed |
| 7036923 | Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function. | Ann Surg | 1982 | https://conductscience.org/library/papers/7036923 | PubMed |
| 3977436 | Amikacin concentrations in serum following intraoperative irrigation of the pleura and peritoneum. | Ann Surg | 1985 | https://conductscience.org/library/papers/3977436 | PubMed |
| 2360818 | Vancomycin pharmacokinetics in burn patients and intravenous drug abusers. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2360818 | PubMed |
| 2360811 | Increased aminoglycoside dosage requirements in hematologic malignancy. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2360811 | PubMed |
| 2180612 | Pathophysiology and pharmacokinetics following burn injury. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2180612 | PubMed |
| 2014982 | Aztreonam pharmacokinetics in burn patients. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2014982 | PubMed |
| 1929317 | Gentamicin pharmacokinetics in patients with malignancies. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1929317 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/715674
GET https://conductscience.org/api/papers/v1/715674/authors